Amneal Pharmaceuticals (AMRX) Inventory (2017 - 2026)

Amneal Pharmaceuticals has reported Inventory for 10 years, with the latest figure at $678.0 million in Q2 2026.

• On a quarterly basis, Inventory rose 11.33% year-over-year to $678.0 million in Q2 2026; TTM through Jun 2026 was $678.0 million, a 11.33% increase from a year earlier, with the FY2025 full-year figure at $606.3 million, down 1.0% from the prior year.
• Inventory was $678.0 million for Q2 2026 at Amneal Pharmaceuticals, up from $641.6 million in the prior quarter.
• The five-year high for Inventory was $678.0 million in Q2 2026, with the low at $512.2 million in Q1 2022.
• Average Inventory over 5 years is $581.3 million, with a median of $578.9 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Inventory slipped 1.0% in 2025, then rose 11.33% in 2026.
• Over 5 years, Inventory stood at $530.7 million in 2022, then increased by 9.54% to $581.4 million in 2023, then gained by 5.34% to $612.5 million in 2024, then declined by 1.0% to $606.3 million in 2025, then increased by 11.82% to $678.0 million in 2026.
• The last three Inventory figures came in at $678.0 million (Q2 2026), $641.6 million (Q1 2026), and $606.3 million (Q4 2025), per Business Quant data.